Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission.

PubWeight™: 1.36‹?› | Rank: Top 10%

🔗 View Article (PMID 11755789)

Published in J Physiol Paris on December 28, 2001

Authors

Frédéric A Meunier1, Giampietro Schiavo, Jordi Molgó

Author Affiliations

1: Molecular NeuroPathobiology Laboratory, Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX, UK. f.meunier@icrf.icnet.uk

Articles citing this

Laboratory diagnostics of botulism. Clin Microbiol Rev (2006) 2.32

Recovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin A. J Physiol (2008) 1.04

Abrogating Munc18-1-SNARE complex interaction has limited impact on exocytosis in PC12 cells. J Biol Chem (2009) 1.03

Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons. PLoS Pathog (2012) 1.00

Ciliary neurotrophic factor is not required for terminal sprouting and compensatory reinnervation of neuromuscular synapses: re-evaluation of CNTF null mice. Exp Neurol (2007) 0.98

Distinct muscarinic acetylcholine receptor subtypes contribute to stability and growth, but not compensatory plasticity, of neuromuscular synapses. J Neurosci (2009) 0.96

Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology. Pharmacol Rev (2017) 0.87

Control of autophagosome axonal retrograde flux by presynaptic activity unveiled using botulinum neurotoxin type a. J Neurosci (2015) 0.87

Synthetic self-assembling clostridial chimera for modulation of sensory functions. Bioconjug Chem (2013) 0.85

Wound botulism in drug users: a still underestimated diagnosis. Neurol Sci (2010) 0.83

Spinal botulinum neurotoxin B: effects on afferent transmitter release and nociceptive processing. PLoS One (2011) 0.83

The Practical Use of AbobotulinumtoxinA in Aesthetics. Aesthet Surg J (2017) 0.83

Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine. Neuropsychiatr Dis Treat (2012) 0.82

Bacterial toxins and the nervous system: neurotoxins and multipotential toxins interacting with neuronal cells. Toxins (Basel) (2010) 0.81

Modulation of inflammatory mediators in the trigeminal ganglion by botulinum neurotoxin type A: an organ culture study. J Headache Pain (2015) 0.81

Modulating neuromuscular junction density changes in botulinum toxin-treated orbicularis oculi muscle. Invest Ophthalmol Vis Sci (2011) 0.80

Systems analysis of transcriptional data provides insights into muscle's biological response to botulinum toxin. Muscle Nerve (2014) 0.80

Botulinum neurotoxin type-A enters a non-recycling pool of synaptic vesicles. Sci Rep (2016) 0.80

Dramatic changes in muscle contractile and structural properties after 2 botulinum toxin injections. Muscle Nerve (2015) 0.80

Type C botulinum toxin causes degeneration of motoneurons in vivo. Neuroreport (2010) 0.79

The setting of a botulinum toxin treatment service. Neurol Sci (2014) 0.78

Persistence of Botulinum neurotoxin inactivation of nerve function. Curr Top Microbiol Immunol (2013) 0.78

Degeneration and regeneration of murine skeletal neuromuscular junctions after intramuscular injection with a sublethal dose of Clostridium sordellii lethal toxin. Infect Immun (2004) 0.78

Sheep monoclonal antibodies prevent systemic effects of botulinum neurotoxin A1. Toxins (Basel) (2012) 0.78

BOTOX: Broadening the Horizon of Dentistry. J Clin Diagn Res (2014) 0.77

Botulinum toxin pretreatment augments the weakening effect of injection with ricin-mAb35 in rabbit extraocular muscle. J AAPOS (2008) 0.77

Cargo-delivery platforms for targeted delivery of inhibitor cargos against botulism. Curr Top Med Chem (2014) 0.77

Acrylamide inhibits nerve sprouting induced by botulinum toxin type A. Neural Regen Res (2014) 0.76

Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody. Toxins (Basel) (2016) 0.75

Characterizing the Bladder's Response to Onabotulinum Toxin Type A Using a Rat Model. Female Pelvic Med Reconstr Surg (2016) 0.75

Occurrence of human pathogenic Clostridium botulinum among healthy dairy animals: an emerging public health hazard. Pathog Glob Health (2016) 0.75

Nonparalytic botulinum molecules for the control of pain. Pain (2016) 0.75

Single intracerebroventricular injection of botulinum toxin type A produces slow onset and long-term memory impairment in rats. J Neural Transm (Vienna) (2009) 0.75

Functional end-plate recovery in long-term botulinum toxin therapy of hemifacial spasm: a nerve conduction study. Neurol Sci (2012) 0.75

Articles by these authors

Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell (2010) 4.62

Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science (2003) 4.40

Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron (2006) 2.79

MICU1 is an essential gatekeeper for MCU-mediated mitochondrial Ca(2+) uptake that regulates cell survival. Cell (2012) 2.75

MCUR1 is an essential component of mitochondrial Ca2+ uptake that regulates cellular metabolism. Nat Cell Biol (2012) 2.48

Activation of MDA5 requires higher-order RNA structures generated during virus infection. J Virol (2009) 2.37

A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J Cell Biol (2005) 2.01

Immunocytochemical techniques reveal multiple, distinct cellular pools of PtdIns4P and PtdIns(4,5)P(2). Biochem J (2009) 2.00

Purification and characterization of the human elongator complex. J Biol Chem (2001) 1.97

Activation of the p75 neurotrophin receptor through conformational rearrangement of disulphide-linked receptor dimers. Neuron (2009) 1.96

Equivalent effects of snake PLA2 neurotoxins and lysophospholipid-fatty acid mixtures. Science (2005) 1.92

Deficits in axonal transport precede ALS symptoms in vivo. Proc Natl Acad Sci U S A (2010) 1.66

Botulinal neurotoxins: revival of an old killer. Curr Opin Pharmacol (2005) 1.66

ADP ribosylation factor 6 (ARF6) controls amyloid precursor protein (APP) processing by mediating the endosomal sorting of BACE1. Proc Natl Acad Sci U S A (2011) 1.60

SNARE complexes and neuroexocytosis: how many, how close? Trends Biochem Sci (2005) 1.58

Structural determinants in phycotoxins and AChBP conferring high affinity binding and nicotinic AChR antagonism. Proc Natl Acad Sci U S A (2010) 1.48

Presynaptic receptor arrays for clostridial neurotoxins. Trends Microbiol (2004) 1.42

A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins. Nat Rev Microbiol (2010) 1.39

Analysis of retrograde transport in motor neurons reveals common endocytic carriers for tetanus toxin and neurotrophin receptor p75NTR. J Cell Biol (2002) 1.38

Evidence for inhibition of cholinesterases in insect and mammalian nervous systems by the insect repellent deet. BMC Biol (2009) 1.38

Long chain polyunsaturated fatty acids are required for efficient neurotransmission in C. elegans. J Cell Sci (2003) 1.38

CAR-associated vesicular transport of an adenovirus in motor neuron axons. PLoS Pathog (2009) 1.35

Interaction of tau protein with the dynactin complex. EMBO J (2007) 1.33

Coordinated regulation of AP2 uncoating from clathrin-coated vesicles by rab5 and hRME-6. J Cell Biol (2008) 1.31

Total synthesis of pinnatoxins A and G and revision of the mode of action of pinnatoxin A. J Am Chem Soc (2011) 1.30

The dystonia-associated protein torsinA modulates synaptic vesicle recycling. J Biol Chem (2007) 1.23

Tetanus toxin is internalized by a sequential clathrin-dependent mechanism initiated within lipid microdomains and independent of epsin1. J Cell Biol (2006) 1.23

The journey of tetanus and botulinum neurotoxins in neurons. Trends Microbiol (2003) 1.23

Molecular landmarks along the axonal route: axonal transport in health and disease. Curr Opin Cell Biol (2008) 1.23

Spastin and microtubules: Functions in health and disease. J Neurosci Res (2007) 1.22

Spatially distinct binding of Cdc42 to PAK1 and N-WASP in breast carcinoma cells. Mol Cell Biol (2005) 1.21

Myosin Va and microtubule-based motors are required for fast axonal retrograde transport of tetanus toxin in motor neurons. J Cell Sci (2003) 1.20

Ins(1,4,5)P3 receptor-mediated Ca2+ signaling and autophagy induction are interrelated. Autophagy (2011) 1.16

Human spastin has multiple microtubule-related functions. J Neurochem (2005) 1.16

Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer's disease mice. J Neurosci (2012) 1.16

Phosphatidylinositol 3-kinase C2alpha is essential for ATP-dependent priming of neurosecretory granule exocytosis. Mol Biol Cell (2005) 1.16

Tetanus toxin is transported in a novel neuronal compartment characterized by a specialized pH regulation. J Biol Chem (2005) 1.14

Neurotrophins Redirect p75NTR from a clathrin-independent to a clathrin-dependent endocytic pathway coupled to axonal transport. Traffic (2007) 1.14

Elimination of plasma membrane phosphatidylinositol (4,5)-bisphosphate is required for exocytosis from mast cells. J Cell Sci (2006) 1.10

Analysis of lectin binding to glycolipid complexes using combinatorial glycoarrays. Glycobiology (2009) 1.06

Central effects of tetanus and botulinum neurotoxins. Toxicon (2009) 1.05

Kidins220/ARMS is transported by a kinesin-1-based mechanism likely to be involved in neuronal differentiation. Mol Biol Cell (2006) 1.05

Xestospongin B, a competitive inhibitor of IP3-mediated Ca2+ signalling in cultured rat myotubes, isolated myonuclei, and neuroblastoma (NG108-15) cells. FEBS Lett (2005) 1.05

Kidins220/ARMS regulates Rac1-dependent neurite outgrowth by direct interaction with the RhoGEF Trio. J Cell Sci (2010) 1.05

Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag--implications for research into amyotrophic lateral sclerosis (ALS). PLoS One (2010) 1.05

TorsinA and dystonia: from nuclear envelope to synapse. J Neurochem (2009) 1.04

The marine phycotoxin gymnodimine targets muscular and neuronal nicotinic acetylcholine receptor subtypes with high affinity. J Neurochem (2008) 1.04

Nuclear inositol 1,4,5-trisphosphate receptors regulate local Ca2+ transients and modulate cAMP response element binding protein phosphorylation. J Cell Sci (2005) 1.02

Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions. Br J Pharmacol (2003) 1.02

Regulation of acetylcholine release by muscarinic receptors at the mouse neuromuscular junction depends on the activity of acetylcholinesterase. Eur J Neurosci (2002) 1.00

Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons. PLoS Pathog (2012) 1.00

Mutant torsinA, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells. Mov Disord (2005) 1.00

Botulinum neurotoxins: mechanism of action. Toxicon (2012) 0.99

Glycerotoxin from Glycera convoluta stimulates neurosecretion by up-regulating N-type Ca2+ channel activity. EMBO J (2002) 0.99

Ligand-independent signaling by disulfide-crosslinked dimers of the p75 neurotrophin receptor. J Cell Sci (2009) 0.99

Large-scale pathways-based association study in amyotrophic lateral sclerosis. Brain (2007) 0.98

Endocytosis and retrograde axonal traffic in motor neurons. Biochem Soc Symp (2005) 0.97

Pinnatoxin G is responsible for atypical toxicity in mussels (Mytilus galloprovincialis) and clams (Venerupis decussata) from Ingril, a French Mediterranean lagoon. Toxicon (2013) 0.97

Liaisons dangereuses: autophagy, neuronal survival and neurodegeneration. Curr Opin Neurobiol (2008) 0.97

Impaired neuromuscular transmission and skeletal muscle fiber necrosis in mice lacking Na/Ca exchanger 3. J Clin Invest (2004) 0.97

Receptor-dependent and -independent axonal retrograde transport of poliovirus in motor neurons. J Virol (2009) 0.96

The SOD1 transgene in the G93A mouse model of amyotrophic lateral sclerosis lies on distal mouse chromosome 12. Amyotroph Lateral Scler Other Motor Neuron Disord (2005) 0.95

Kidins220/ARMS as a functional mediator of multiple receptor signalling pathways. J Cell Sci (2012) 0.95

VAMP/synaptobrevin cleavage by tetanus and botulinum neurotoxins is strongly enhanced by acidic liposomes. FEBS Lett (2003) 0.95

IP(3)-dependent, post-tetanic calcium transients induced by electrostimulation of adult skeletal muscle fibers. J Gen Physiol (2010) 0.95

Alternative fates of newly formed PrPSc upon prion conversion on the plasma membrane. J Cell Sci (2013) 0.93

The phagocytic capacity of neurones. Eur J Neurosci (2007) 0.93

Neurotoxic cyanobacterial toxins. Toxicon (2009) 0.93

Absence of disturbed axonal transport in spinal and bulbar muscular atrophy. Hum Mol Genet (2011) 0.91

A motor-driven mechanism for cell-length sensing. Cell Rep (2012) 0.90

CSN complex controls the stability of selected synaptic proteins via a torsinA-dependent process. EMBO J (2010) 0.90

Disruption of the coxsackievirus and adenovirus receptor-homodimeric interaction triggers lipid microdomain- and dynamin-dependent endocytosis and lysosomal targeting. J Biol Chem (2013) 0.90

Functional recycling of C2 domains throughout evolution: a comparative study of synaptotagmin, protein kinase C and phospholipase C by sequence, structural and modelling approaches. J Mol Biol (2003) 0.90

Brevenal inhibits pacific ciguatoxin-1B-induced neurosecretion from bovine chromaffin cells. PLoS One (2008) 0.90

Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice. Life Sci (2007) 0.90

IP3 receptors and associated Ca2+ signals localize to satellite cells and to components of the neuromuscular junction in skeletal muscle. J Neurosci (2003) 0.89

Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotonia. Hum Mol Genet (2008) 0.89

Stability of cyclic imine toxins: interconversion of pinnatoxin amino ketone and pinnatoxin A in aqueous media. J Org Chem (2012) 0.89

Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C. Eur J Neurosci (2007) 0.89

Sustained synaptic-vesicle recycling by bulk endocytosis contributes to the maintenance of high-rate neurotransmitter release stimulated by glycerotoxin. J Cell Sci (2010) 0.88

The elusive compass of clostridial neurotoxins: deciding when and where to go? Curr Top Microbiol Immunol (2013) 0.88

Detection of gymnodimine-A and 13-desmethyl C spirolide phycotoxins by fluorescence polarization. Anal Chem (2009) 0.87

Internalization of a GFP-tetanus toxin C-terminal fragment fusion protein at mature mouse neuromuscular junctions. Mol Cell Neurosci (2005) 0.87

Re-assembled botulinum neurotoxin inhibits CNS functions without systemic toxicity. Toxins (Basel) (2011) 0.87

A mouse model for congenital myasthenic syndrome due to MuSK mutations reveals defects in structure and function of neuromuscular junctions. Hum Mol Genet (2008) 0.87

First direct fluorescence polarization assay for the detection and quantification of spirolides in mussel samples. Anal Chim Acta (2011) 0.86

A delta-conotoxin from Conus ermineus venom inhibits inactivation in vertebrate neuronal Na+ channels but not in skeletal and cardiac muscles. J Biol Chem (2003) 0.86

A non-radioactive ligand-binding assay for detection of cyanobacterial anatoxins using Torpedo electrocyte membranes. Toxicon (2008) 0.86

Preferential entry of botulinum neurotoxin A Hc domain through intestinal crypt cells and targeting to cholinergic neurons of the mouse intestine. PLoS Pathog (2012) 0.86

Synthetic self-assembling clostridial chimera for modulation of sensory functions. Bioconjug Chem (2013) 0.85

Ciguatoxin-induced catecholamine secretion in bovine chromaffin cells: mechanism of action and reversible inhibition by brevenal. Toxicon (2009) 0.85

A novel µ-conopeptide, CnIIIC, exerts potent and preferential inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptors. Br J Pharmacol (2012) 0.85

Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction. Mol Neurobiol (2013) 0.85

Coupling the Torpedo microplate-receptor binding assay with mass spectrometry to detect cyclic imine neurotoxins. Anal Chem (2012) 0.85

Vesicle size and transmitter release at the frog neuromuscular junction when quantal acetylcholine content is increased or decreased. J Physiol (2002) 0.85

Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders. Toxicon (2012) 0.84

Brain-derived neurotrophic factor facilitates in vivo internalization of tetanus neurotoxin C-terminal fragment fusion proteins in mature mouse motor nerve terminals. Eur J Neurosci (2006) 0.84

Calcium influx and mitochondrial alterations at synapses exposed to snake neurotoxins or their phospholipid hydrolysis products. J Biol Chem (2007) 0.84